Verónica Robles

874 total citations
13 papers, 175 citations indexed

About

Verónica Robles is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Verónica Robles has authored 13 papers receiving a total of 175 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Verónica Robles's work include HER2/EGFR in Cancer Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Platelet Disorders and Treatments (2 papers). Verónica Robles is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Platelet Disorders and Treatments (2 papers). Verónica Robles collaborates with scholars based in United States, Spain and Japan. Verónica Robles's co-authors include Brian A. Mendelsohn, Yutaka Matsuda, James Song, Zhilan Zeng, Sathish Kumar Ganesan, Josh Snyder, David R. Stover, Sher Karki, Héctor Aviña and Monica Leung and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Cancer Research.

In The Last Decade

Verónica Robles

11 papers receiving 171 citations

Peers

Verónica Robles
Josh Snyder United States
Sung-Ju Moon United States
Ludivine Moine United States
John Meekin United States
Jeff Lau United States
Hyking Haley United States
Hilmar Ebersbach Switzerland
Verónica Robles
Citations per year, relative to Verónica Robles Verónica Robles (= 1×) peers Lillian Skidmore

Countries citing papers authored by Verónica Robles

Since Specialization
Citations

This map shows the geographic impact of Verónica Robles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verónica Robles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verónica Robles more than expected).

Fields of papers citing papers by Verónica Robles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verónica Robles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verónica Robles. The network helps show where Verónica Robles may publish in the future.

Co-authorship network of co-authors of Verónica Robles

This figure shows the co-authorship network connecting the top 25 collaborators of Verónica Robles. A scholar is included among the top collaborators of Verónica Robles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verónica Robles. Verónica Robles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kucera, Katerina S., Verónica Robles, Heidi Cope, et al.. (2023). P497: Two years of newborn screening for Duchenne Muscular Dystrophy in North Carolina: Results from Early Check*. SHILAP Revista de lepidopterología. 1(1). 100544–100544.
2.
Robles, Verónica, et al.. (2023). Kollicoat MAE® 100P as a film former polymer for nanoparticles preparation. Revista Colombiana de Ciencias Químico Farmacéuticas. 51(3). 1 indexed citations
3.
Matsuda, Yutaka, et al.. (2020). Proof of site-specificity of antibody-drug conjugates produced by chemical conjugation technology: AJICAP first generation. Journal of Chromatography B. 1140. 121981–121981. 26 indexed citations
4.
Matsuda, Yutaka, et al.. (2020). Analytical Comparison of Antibody-drug Conjugates Based on Good Manufacturing Practice Strategies. Analytical Sciences. 36(7). 871–875. 28 indexed citations
5.
Fernández, Roberto J., Felipe X. Cepeda, Á. Sánchez-González, et al.. (2019). PB2182 OUTCOME OF FIRST‐LINE THERAPY FOR PATIENTS WITH SYSTEMIC LIGHT‐CHAIN AMYLOIDOSIS: MONOCENTRIC ANALYSIS. HemaSphere. 3(S1). 979–979. 1 indexed citations
6.
Robles, Verónica, et al.. (2019). Factores para la adherencia terapéutica en personas con hipertensión y diabetes.. 2(3). 25–33. 2 indexed citations
8.
Matsuda, Yutaka, et al.. (2019). Comparison of Analytical Methods for Antibody–Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP. Analytical Chemistry. 91(20). 12724–12732. 32 indexed citations
9.
Fernández, Rubén, Ana Pilar González, Ángel Ramírez Páyer, et al.. (2019). Outcome of first-line therapy in patients with systemic light-chain amyloidosis: A multicentre analysis. Clinical Lymphoma Myeloma & Leukemia. 19(10). e333–e334. 1 indexed citations
10.
Zhao, Hui, Sathish Kumar Ganesan, Karen Morrison, et al.. (2017). Inhibition of Megakaryocyte Differentiation by Antibody–Drug Conjugates (ADCs) is Mediated by Macropinocytosis: Implications for ADC-induced Thrombocytopenia. Molecular Cancer Therapeutics. 16(9). 1877–1886. 47 indexed citations
11.
Zhao, Hui, Sathish Kumar Ganesan, Zhilan Zeng, et al.. (2016). Abstract 3853: Potential mechanisms for thrombocytopenia and neutropenia induced by antibody-drug conjugates. Cancer Research. 76(14_Supplement). 3853–3853. 1 indexed citations
12.
Robles, Verónica, et al.. (2014). Heparin-induced thrombocytopenia in haemodialysis treated with argatroban.. PubMed. 34(5). 670–4. 4 indexed citations
13.
Araya, Julia, et al.. (1999). Acidos grasos poliinssaturados de cadena larga en eritrocitos de prematuros alimentados por vía enteral con leche humana de pretérmino o con una fórmula convencional. Revista chilena de pediatría. 70(2). 100–106. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026